These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4326036)

  • 1. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
    Wolberg WH
    Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
    [No Abstract]   [Full Text] [Related]  

  • 2. Some immunologic characteristics of carcinoma of the colon and rectum.
    Elias EG; Elias LL
    Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoembryonic antigen in oncology].
    Tkacheva GA
    Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
    Zöller M; Matzku S; Schulz U; Price MR
    J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-specific cellular immunity.
    Cohen AM; Burdick JF; Ketcham AS
    J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utilization of the migration inhibition and blast transformation reactions of the peripheral blood leukocytes for indicating neoplastic delayed hypersensitivity].
    Mkrtchian VA; Galstian AM; Zurabian AS; Dzhandzhapanian SP; Sevunts LG
    Zh Eksp Klin Med; 1975; 15(1):19-23. PubMed ID: 1136619
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocompetence testing in patients with one of the four common operable cancers--a review.
    Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
    Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the immunologic sensitizability of tumor patients].
    Hegemann F
    Arch Geschwulstforsch; 1968; 32(4):339-52. PubMed ID: 4308112
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition.
    Elias EG; Elias LL; Didolkar MS; Hebel JR
    Cancer; 1977 Aug; 40(2):687-92. PubMed ID: 890653
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro studies of delayed hypersensitivity in man. I. Specific cell migration inhibition].
    Patrucco A; Cisneros ME
    Medicina (B Aires); 1971; 31(2):85-8. PubMed ID: 5566444
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hypersensitivity skin and leucocyte migration inhibition tests in chronic liver disease.
    el-Din SS; el-Zayady A; Montaser MF; Khalil RY
    J Egypt Soc Parasitol; 1984 Dec; 14(2):593-8. PubMed ID: 6096452
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.
    Paque RE; Meltzer MS; Zbar B; Rapp HJ; Dray S
    Cancer Res; 1973 Dec; 33(12):3165-71. PubMed ID: 4357351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.